Thyroid dysfunction and immune checkpoint inhibitor outcomes.

被引：0
|
作者：
von Itzstein, Mitchell S.
Lu, Rong
Ali, Sadia
Xie, Donglu
Cai, Jennifer
Xie, Yang
Gerber, David E.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15103
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
    Muir, Christopher A.
    Clifton-Bligh, Roderick J.
    Long, Georgina, V
    Scolyer, Richard A.
    Lo, Serigne N.
    Carlino, Matteo S.
    Tsang, Venessa H. M.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3704 - E3713
  • [22] Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer
    Muir, Christopher A.
    Menzies, Alexander M.
    Clifton-Bligh, Roderick
    Tsang, Venessa H. M.
    THYROID, 2020, 30 (10) : 1458 - 1469
  • [23] Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
    Farina, Antonio
    Birzu, Cristina
    Elsensohn, Mad-Helenie
    Picca, Alberto
    Muniz-Castrillo, Sergio
    Vogrig, Alberto
    Villagran-Garcia, Macarena
    Ciano-Petersen, Nicolas Lundahl
    Massacesi, Luca
    Hervier, Baptiste
    Guegan, Sarah
    Kramkimel, Nora
    Vano, Yann
    Salem, Joe Elie
    Allenbach, Yves
    Maisonobe, Thierry
    Assaad, Souad
    Maureille, Aurelien
    Devic, Perrine
    Weiss, Nicolas
    Pegat, Antoine
    Maucort-Boulch, Delphine
    Ricard, Damien
    Honnorat, Jerome
    Psimaras, Dimitri
    Joubert, Bastien
    BRAIN COMMUNICATIONS, 2023, 5 (03)
  • [24] UNUSUAL CARDIOVASCULAR AUTONOMIC DYSFUNCTION SECONDARY TO IMMUNE CHECKPOINT INHIBITOR THERAPY
    Danley, Kelsey T.
    Fidler, Mary
    Sadaf, Aliyah
    Okwuosa, Tochi M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2823 - 2823
  • [25] Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction
    Wright, Jordan J.
    Johnson, Douglas B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06): : 1514 - 1525
  • [26] Impact of neoadjuvant immune checkpoint inhibitor therapy on primary tumor size and complexity: Correlation with surgical quality and short term oncological outcomes.
    Saidian, Ava
    Hakimi, Kevin
    Panian, Justine
    Ajmera, Archana
    Barata, Pedro C.
    Berg, Stephanie A.
    Chang, Steven Lee
    Choueiri, Toni K.
    Dzimitrowicz, Hannah Elizabeth
    Emamekhoo, Hamid
    Gross, Evan
    Kilari, Deepak
    Lam, Elaine Tat
    Nonato, Taylor
    Psutka, Sarah P.
    Thapa, Bicky
    Weise, Nicole
    Zhang, Tian
    Mckay, Rana R.
    Derweesh, Ithaar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [27] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
    Suresh, Karthik
    D'Alessio, Franco
    CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
  • [28] Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction
    Olsson-Brown, Anna
    Lord, Rosemary
    Sacco, Joseph
    Wagg, Jonathan
    Coles, Mark
    Pirmohamed, Munir
    ENDOCRINE CONNECTIONS, 2020, 9 (04): : 318 - 325
  • [29] Thyroid dysfunction associated with immune checkpoint blockade: An emerging immune-related adverse event
    Choy, Kay Hau
    ANNALS OF ONCOLOGY, 2021, 32 : S355 - S355
  • [30] Immune Checkpoint Inhibitors-induced Thyroid Dysfunction in Patients with Advanced Malignancies
    Latif, Muhammad Farooq
    Abdelgadir, Elamin
    Omara, Mohamed
    Rashid, Fauzia
    Tirmazy, Syed H.
    Khan, Faraz
    El Khoury, Maroun
    Bashier, Alaaeldin
    Alawadi, Fatheya
    Das, Kaltar
    Kumar, Susheel
    Basit, Abdul Q.
    El-Shourbagy, Dalia
    Hamza, Dina
    Azam, Faisal
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (04) : 616 - 623
12345